Evidence map›Paper›PMID 38682738›Full record

ArticleFuture oncology (London, England)2024

Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).

Fabio Catalano, Matteo Brunelli, Alessio Signori, Pasquale Rescigno, Sebastiano Buti, Luca Galli, Massimiliano Spada, Cristina Masini, Francesca Galuppini, Valerio Gaetano Vellone and 17 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Fabio CatalanoMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.ORCID 0000-0002-0722-7692
Matteo BrunelliPathology Unit, Department of Diagnostics & Public Health, University & Hospital Trust of Verona, 37124, Verona, Italy.
Alessio SignoriDepartment of Health Sciences (DISSAL), Section of Biostatistics, University of Genoa, 16132, Genoa, Italy.ORCID 0000-0001-6289-9144
Pasquale RescignoCandiolo Cancer Institute, FPO-IRCCS, 10060, Candiolo, Italy.ORCID 0000-0002-4668-4765
Sebastiano ButiDepartment of Medicine and Surgery, University of Parma, 43126, Parma, Italy.ORCID 0000-0003-0876-0226
Luca GalliMedical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, 56126, Pisa, Italy.
Massimiliano SpadaUOC Oncologia Medica, Istituto Fondazione G. Giglio, 90015, Cefalù, Italy.
Cristina MasiniMedical Oncology Unit, Clinical Cancer Centre, AUSL-IRCCS di Reggio Emilia, 42122, Reggio Emilia, Italy.
Francesca GaluppiniSurgical Pathology Unit, Department of Medicine (DIMED), University of Padua, 35128, Padua, Italy.
Valerio Gaetano VellonePathology Unit, IRCCS Istituto Giannina Gaslini, 16147, Genoa, Italy.
Gabriele GaggeroPathology Unit, IRCCS Istituto Giannina Gaslini, 16147, Genoa, Italy.
Marco MaruzzoOncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, 35128, Padua, Italy.ORCID 0000-0002-6256-9249
Sara MerlerSection of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine, University of Verona & Verona University & Hospital Trust, Verona, 37134, Italy.
Francesca VignaniDivision of Medical Oncology, Ordine Mauriziano Hospital, 10128, Turin, Italy.
Alessia CavoOncology Unit, Villa Scassi Hospital, 16149, Genoa, Italy.
Davide BimbattiOncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, 35128, Padua, Italy.
Michele MilellaSection of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine, University of Verona & Verona University & Hospital Trust, Verona, 37134, Italy.
Angelo Paolo Dei TosSurgical Pathology Unit, Department of Medicine (DIMED), University of Padua, 35128, Padua, Italy.
Marta SbaragliaSurgical Pathology Unit, Department of Medicine (DIMED), University of Padua, 35128, Padua, Italy.
Veronica MurianniMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
Alessandra DamassiMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
Malvina CremanteMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
Michele MaffezzoliDepartment of Medicine and Surgery, University of Parma, 43126, Parma, Italy.ORCID 0000-0001-7877-8988
Miguel Angel Llaja ObispoMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
Giuseppe Luigi BannaDepartment of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK.ORCID 0000-0003-0764-3650
Giuseppe FornariniMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.ORCID 0000-0003-4754-6572
Sara Elena RebuzziMedical Oncology Unit, Ospedale San Paolo, 17100, Savona, Italy.ORCID 0000-0003-0546-6304

Funding

LILT-Lega Italiana per la Lotta ai Tumori Bando 5 × 1000 2019
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsTumor MicroenvironmentAdultAgedAntineoplastic Agents, ImmunologicalBiomarkers, TumorFemaleHumansImmune Checkpoint InhibitorsImmunotherapyLymphocytes, Tumor-InfiltratingMaleMiddle AgedNivolumabProgression-Free SurvivalAntineoplastic Agents, ImmunologicalBiomarkers, TumorImmune Checkpoint InhibitorsNivolumabCD4CD56CD8immune checkpoint inhibitorimmunotherapyPD-L1renal cell carcinomatumor microenvironment

Identifiers

PMID38682738
PMCPMC11441071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.